Companies Dominating the In Vitro Fertilization (IVF) Hormones Landscape
- Merck KGaA
- Company overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- SWOT Analysis
- GENPHARM
- Aquatic Group
- BioVendor – Laboratorni medicina a.s.
- Biogenix Inc. Pvt. Ltd.
- Midas Pharma GmbH
- Empower Pharmacy
- Kamiya Biomedical Company
- BBI Solutions
- Lee Biosolutions, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In Vitro Fertilization (IVF) Hormones Market size is set to register remarkable growth rate during the forecast period i.e., between 2025-2037.
Increasing incidences of infertility worldwide, and the need amongst individuals to opt for IVF treatments, will impel the market growth.
Europe industry is likely to hold largest revenue share by 2037, backed by increasing adoption of IVF procedures amongst individuals, and increasing support of the government for raising awareness for IVF treatments.
The major players in the market are Merck KGaA (OTCMKTS: MKKGY), GENPHARM, Aquatic Group, BioVendor – Laboratorni medicina a.s., Biogenix Inc. Pvt. Ltd., and others.
